- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01154686
Working Memory Training in College Students With Attention-Deficit Hyperactivity Disorder/Learning Disabilities
Working Memory Training in College Students With ADHD/LD
The overall objective of the current study is to determine whether computerized Working Memory (WM) training will enhance WM capacity in college students with Attention Deficit Hyperactivity Disorder (ADHD)/Learning Disabilities (LD). There are also three additional objectives. The first is to determine whether improvements in WM will generalize to secondary outcome tasks, such as inhibitory control and planning. The second objective is to examine whether WM training will also ameliorate ADHD symptoms of inattention and hyperactivity. The last objective is to investigate whether improvements will be maintained at a two month follow-up period.
It is expected that the computerized WM training program will enhance WM capacity in college students with ADHD. In addition, it is believed that these increases in WM capacity will also lead to improvements in other executive functions. It is also hypothesized that WM training will lead to a reduction in ADHD symptomology. Lastly, these improvements should be maintained at three month follow-up.
Study Overview
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada
- Recruiting
- University of Toronto
-
Contact:
- Rachel Gropper, MA
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of ADHD/Learning Disability
- registered as a university student (full or part time)
- registered at accessibilities services
- taking at least one course
Exclusion Criteria:
- On a leave
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Paced Auditory Serial Addition Test (auditory verbal working memory measure)
Time Frame: within 120 days
|
within 120 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cognitive Failures Questionnaire
Time Frame: within 120 days
|
within 120 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Rachel Gropper, MA, University of Toronto
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23977
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Disorder
-
King's College LondonActive, not recruitingAttention-Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder SymptomsUnited Kingdom
-
Qbtech ABEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD)United States
-
Universidade do Sul de Santa CatarinaAssociação Brasileira de Cannabis MedicinalRecruitingAttention-Deficit/Hyperactivity Disorder (ADHD)Brazil
-
Nanjing Medical UniversityRecruitingAdult Attention Deficit Hyperactivity DisorderChina
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia and other collaboratorsNot yet recruitingAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Disorder With HyperactivityUnited States
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); National Institutes of Health (NIH)TerminatedAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder | Working MemoryUnited States
-
Cingulate TherapeuticsSuspendedPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Tongren Hongxin Kangxin Traditional Chinese Medicine...CompletedAttention Deficit Hyperactivity DisorderChina
-
Aytu BioPharma, Inc.Premier Research Group plcWithdrawnAttention Deficit Hyperactivity DisorderUnited States
Clinical Trials on Cogmed
-
Duke UniversityCompletedCognitive Impairment | Sickle Cell DiseaseUnited States
-
Indiana UniversityCompletedBilateral Hearing LossUnited States
-
St. Joseph's Hospital and Medical Center, PhoenixBarrow Neurological Institute; Barrow Neurological FoundationRecruitingMild Cognitive Impairment (MCI)United States
-
KU LeuvenActive, not recruitingCerebral PalsyBelgium
-
University of California, DavisCompletedADHD | AttentionUnited States
-
University of HawaiiNational Institute on Drug Abuse (NIDA); University of Maryland, BaltimoreUnknown
-
Children's National Research InstituteRecruitingSickle Cell DiseaseUnited States
-
University of Sao Paulo General HospitalCompleted
-
Kessler FoundationCompleted
-
Virginia Commonwealth UniversityCompletedGlioma | Brain Tumor, PrimaryUnited States